The partnership is already underway having launched earlier last week, and the contract could be worth up to £211 million.
The supplemental adolescent approval enhances Solosec’s strong position as the first and only single-dose oral prescription antimicrobial agent approved for the treatment of both trichomoniasis and BV
The service has already been initiated in Maharashtra but being net-based it is easily available for patients all across the country
Singapore Health Sciences Authority (HSA) approval marks the first in a series of expected approvals of trodelvy in Asia
A National Tele Mental Health Programme is being launched to address mental health issues. We spoke to healthcare industry leaders who shared their outlook
SOLOSEC is designed to be easy to take and one oral dose contains a complete course of treatment
UCB plans to submit regulatory applications in Q3 2022
However, these won’t be available at the nearest chemist store soon
The companies were evaluated via a comprehensive, in-depth assessment process that included a sustainability framework of 300 points each for – Purpose, Partnership, Planet and People
Danny Bar-Zohar will become Global Head of R&D and Joern-Peter Halle will become Chief Strategy Officer
Subscribe To Our Newsletter & Stay Updated
